Tango Therapeutics Inc (TNGX)
3.90
+0.34
(+9.55%)
USD |
NASDAQ |
Nov 14, 16:00
3.90
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Profit Margin (Quarterly): -251.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -251.3% |
| June 30, 2024 | -128.6% |
| March 31, 2024 | -585.9% |
| December 31, 2023 | -566.4% |
| September 30, 2023 | -207.4% |
| June 30, 2023 | -141.9% |
| March 31, 2023 | -485.7% |
| December 31, 2022 | -453.3% |
| Date | Value |
|---|---|
| September 30, 2022 | -419.8% |
| June 30, 2022 | -430.7% |
| March 31, 2022 | -437.8% |
| December 31, 2021 | -385.7% |
| September 30, 2021 | -288.6% |
| June 30, 2021 | -24.75% |
| March 31, 2021 | -189.6% |
| December 31, 2020 | -96.96% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-585.9%
Minimum
Mar 2024
-24.75%
Maximum
Jun 2021
-318.4%
Average
-337.2%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.54% |
| Return on Assets | -31.31% |
| Return on Invested Capital | -48.54% |
| Operating Margin (Quarterly) | -283.3% |
| Return on Net Operating Assets | -238.0% |